 |
|
|
| |
Sustained virological response after treatment with
Bulevirtide in HDV patients. Data from the french multicenter real-life cohort
|
| |
| |
EASL 2024 June 5-8 Milan Italy
V. de Lédinghen1, K. Lacombe2, S. Pol3, L. Alric4, C. Lascoux-Combe5, D. Alfaiate6, M.N. Hilleret7, N. Ganne8, J. Gournay9, V. Loustaud-Ratti10, M. Subic-Levrero6, F. Coulibaly11, E. Le Pabic12, C. Tual12, S. Brichler13, F. Zoulim11
1 Haut-Lévêque Hospital, Bordeaux ; 2 AP-HP, Saint Antoine Hospital, Paris ; 3 AP-HP, Cochin Hospital, Paris ; 4 Rangueil Hospital, Toulouse ; 5 AP-HP, Saint Louis Hospital, Paris ; 6 HCL, Croix Rousse Hospital, Lyon ; 7 Michallon Hospital, Grenoble; 8 AP-HP, Avicenne Hospital, Bobigny; 9 Hôtel-Dieu Hospital, Nantes; 10 Dupuytren Hospital, Limoges; 11 ANRS, Paris; 12 Pontchaillou Hospital, CIC 1414, INSERM, Rennes; 13 CNR Avicenne Hospital, Bobigny; 14 HCL Croix Rousse Hospital, Claude Bernard Lyon 1 University, INSERM U1054, Lyon
|
| |
|
|
|
|
|
